Annie Harroche

896 total citations
38 papers, 299 citations indexed

About

Annie Harroche is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Annie Harroche has authored 38 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 11 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Annie Harroche's work include Hemophilia Treatment and Research (18 papers), Platelet Disorders and Treatments (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers). Annie Harroche is often cited by papers focused on Hemophilia Treatment and Research (18 papers), Platelet Disorders and Treatments (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers). Annie Harroche collaborates with scholars based in France, United States and Türkiye. Annie Harroche's co-authors include S. Hadj‐Rabia, Christine Bodemer, Sylvie Fraïtag, Pierre Lemaire, Dominique Lasne, A. Dompmartin, Jacob Mashiah, S. Guéro, Jean–Claude Souberbielle and J C Amoric and has published in prestigious journals such as Blood, PLoS ONE and Journal of the American Academy of Dermatology.

In The Last Decade

Annie Harroche

34 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Harroche France 10 140 68 63 43 37 38 299
György Pfliegler Hungary 10 176 1.3× 25 0.4× 147 2.3× 68 1.6× 37 1.0× 30 335
Robert P New United Kingdom 4 39 0.3× 108 1.6× 41 0.7× 12 0.3× 22 0.6× 10 267
Amira A. Shahin Egypt 10 54 0.4× 133 2.0× 43 0.7× 27 0.6× 9 0.2× 33 287
Christian L. Stallworth United States 4 100 0.7× 191 2.8× 60 1.0× 33 0.8× 12 0.3× 6 302
Satyapal Rangaraj United Kingdom 7 52 0.4× 166 2.4× 54 0.9× 12 0.3× 16 0.4× 17 265
Sung-Chao Chu Taiwan 9 154 1.1× 23 0.3× 36 0.6× 23 0.5× 62 1.7× 17 246
Cathy Sparling Canada 8 239 1.7× 49 0.7× 21 0.3× 52 1.2× 40 1.1× 9 329
Teresa Contreras Spain 12 36 0.3× 16 0.2× 84 1.3× 23 0.5× 28 0.8× 19 252
Elena Aurrecoechea Spain 11 53 0.4× 200 2.9× 76 1.2× 16 0.4× 63 1.7× 28 308
A Dinç Türkiye 13 68 0.5× 184 2.7× 76 1.2× 33 0.8× 6 0.2× 20 400

Countries citing papers authored by Annie Harroche

Since Specialization
Citations

This map shows the geographic impact of Annie Harroche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Harroche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Harroche more than expected).

Fields of papers citing papers by Annie Harroche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Harroche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Harroche. The network helps show where Annie Harroche may publish in the future.

Co-authorship network of co-authors of Annie Harroche

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Harroche. A scholar is included among the top collaborators of Annie Harroche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Harroche. Annie Harroche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbay, Virginie, Yohann Repessé, Dominique Desprez, et al.. (2025). Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST). Thrombosis and Haemostasis. 125(10). 960–971.
2.
Bally, Cécile, Tiffany Pascreau, Anaïs Brassier, et al.. (2025). Is primary hemostasis involved in bleeding diathesis in patients with type 1 glycogen storage disease?. Thrombosis Research. 253. 109424–109424.
3.
Guy, Alexandre, et al.. (2024). Acquired haemophilia A in paediatric patients: A retrospective French cohort of eight cases. British Journal of Haematology. 204(2). 606–611. 2 indexed citations
4.
Beccaria, Kévin, Romain Luscan, François Simon, et al.. (2024). Pediatric intracranial empyema complicating otogenic and sinogenic infection. International Journal of Pediatric Otorhinolaryngology. 177. 111860–111860. 3 indexed citations
5.
Meunier, Sandrine, et al.. (2024). Severe haemorrhages leading to a diagnosis of rare bleeding disorder occur at a very young age: A study from the FranceCoag network. Haemophilia. 30(4). 981–987. 1 indexed citations
6.
Guillet, Benoît, B. Wibaut, Annie Harroche, et al.. (2023). A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis. Thrombosis and Haemostasis. 123(5). 490–500. 2 indexed citations
7.
Rugeri, Lucia, Annie Harroche, S. Combe, et al.. (2022). POSTER PRESENTATIONS. Haemophilia. 28(S1). 25–126. 5 indexed citations
8.
Tardy, Brigitte, Thierry Lambert, Marc Trossaërt, et al.. (2022). Revised terminal half‐life of nonacog alfa as derived from extended sampling data: A real‐world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis. Haemophilia. 28(4). 542–547. 4 indexed citations
9.
Favier, Rémi, Annie Harroche, Dominique Lasne, et al.. (2021). Assessing bleeding risk in 18 children with Osteogenesis imperfecta. British Journal of Haematology. 192(4). 785–788. 2 indexed citations
10.
Cholet, Sophie, Annie Harroche, Sandrine Vuillaumier‐Barrot, et al.. (2021). SLC37A4-CDG: New biochemical insights for an emerging congenital disorder of glycosylation with major coagulopathy. Clinica Chimica Acta. 521. 104–106. 6 indexed citations
11.
Harroche, Annie, Delphine Borgel, Dominique Lasne, et al.. (2021). Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient. Haematologica. 106(8). 2287–2290. 13 indexed citations
12.
Goudemand, Jenny, Françoise Bridey, S. Claeyssens, et al.. (2020). Management of von Willebrand disease with a factor VIII‐poor von Willebrand factor concentrate: Results from a prospective observational post‐marketing study. Journal of Thrombosis and Haemostasis. 18(8). 1922–1933. 12 indexed citations
13.
Rugeri, Lucia, Christophe Martinaud, Philippe Beurrier, et al.. (2020). Gynecological and obstetric outcome in the French cohort of women with factor XIII deficiency. Thrombosis Research. 191. 22–25. 7 indexed citations
15.
l′Escalopier, Nicolas de, Annie Harroche, Laurent Frenzel, et al.. (2017). Long-term results of ankle arthrodesis in children and adolescents with haemophilia. International Orthopaedics. 41(8). 1579–1584. 11 indexed citations
16.
Morice, Anne, et al.. (2017). Preoperative Detailed Coagulation Tests Are Required in Patients With Noonan Syndrome. Journal of Oral and Maxillofacial Surgery. 76(7). 1553–1558. 7 indexed citations
17.
Mashiah, Jacob, S. Hadj‐Rabia, A. Dompmartin, et al.. (2014). Infantile myofibromatosis: A series of 28 cases. Journal of the American Academy of Dermatology. 71(2). 264–270. 59 indexed citations
18.
Lemaire, Pierre, et al.. (2013). Pituitary Stalk Interruption Syndrome in 53 Postpubertal Patients: Factors Influencing the Heterogeneity of Its Presentation. PLoS ONE. 8(1). e53189–e53189. 26 indexed citations
19.
Gendrel, D, et al.. (2011). Pneumocoques isolés dans les pneumonies d’enfants vaccinés. Archives de Pédiatrie. 18(5). 518–521. 1 indexed citations
20.
Busiah, Kanetee, et al.. (2007). Diagnostic des retards pubertaires. Archives de Pédiatrie. 14(9). 1101–1110. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026